The Healthcare Distribution Alliance (HDA) and its pharmaceutical distributor members today released a policy agenda to combat drug shortages. HDA’s recommendations center around three core themes: federal coordination, strategic investment, and end-to-end stabilization of the generic drug supply chain.
“The root causes of drug shortages are varied and complex, requiring distinct approaches and mitigation strategies. As a vital link between 1,500 upstream manufacturers and approximately 330,000 downstream providers, distributors have a unique vantage point that not only helps to minimize the impact of shortages as they occur, but also translates into common-sense policy solutions,” said Nicolette Louissaint, PhD, senior vice resident, policy and strategic planning, HDA. “HDA and its distributor members are committed to working collaboratively with supply chain partners and policymakers to develop solutions that will have the most significant impact on the health of patients.”



















